skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures


(Last updated: September 1, 2014; last reviewed: September 1, 2014)

Non-CMV Herpes
Member Financial Disclosure
Company Relationship
Casper, Corey University of Washington School of Medicine Centocor Research Support
GlaxoSmithKline Scientific Advisory Board
Janssen Pharmaceuticals Consultant, Research Support
Johnson & Johnson Research Support
Sanofi Pasteur Research Support
Temptime Scientific Advisory Board
Durand, Christine Johns Hopkins Gilead Advisory Board, Research Support
Gnann, John Medical University of South Carolina BioCryst DSMB Member
Cellerant DSMB Member
Genocea Biosciences Research Support
GlaxoSmithKline DSMB Member
Merck DSMB Member, Consultant
Jabs, Douglas Mt. Sinai School of Medicine Abbott Consultant
Allergen Consultant
Novartis Consultant
Regeneron  Consultant
Santen Consultant
Jacobson, Mark University of California San Francisco Up To Date Other
Johnston, Christine* University of Washington Agenus Research Support
Aicuris GmhH Research Support
Genocea Research Support
Gilead Research Support
Vical Research Support
Kimberlin, David University of Alabama at Birmingham Cellex Research Support
Gilead Research Support
GlaxoSmithKline Research Support
Wald, Anna University of Washington Agenus Research Support
AiCuris Consultant
Amgen Consultant
Genentech Research Support
Genocea Research Support
Gilead Research Support
Up to Date Other
Vical Research Support
* Group lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from September 1, 2012, through September 1, 2014.

Back to Top